Biocraft Laboratories Incsaid it signed a contract with American Cyanamid Co to makecefixime, a third generation oral cephalosporin.    It said American Cyanamid's Lederle Laboratories filed anew drug application with the Food and Drug Administration forthe product.    According to the agreement, Biocraft will manufacture theproduct for American Cyanamid for the first three years ofcommercial production. Reuter&#3;